Abstract
Preclinical animal studies have continuously reported the possibility of long-lasting neurotoxic effects after general anesthesia in young animals. Such studies also show that the neurological changes induced by anesthesia in young animals differ by their neurodevelopmental stage. Exposure to anesthetic agents increase dendritic spines and induce sex-dependent changes of excitatory/inhibitory synaptic transmission in late postnatal mice, a critical synaptogenic period. However, the mechanisms underlying these changes remain unclear. Abnormal activation of the mammalian target of rapamycin (mTOR) signaling pathway, an important regulator of neurodevelopment, has also been shown to induce similar changes during neurodevelopment. Interestingly, previous studies show that exposure to general anesthetics during neurodevelopment can activate the mTOR signaling pathway. This study, therefore, evaluated the role of mTOR signaling after exposing postnatal day (PND) 16/17 mice to sevoflurane, a widely used inhalation agent in pediatric patients. We first confirmed that a 2-h exposure of 2.5% sevoflurane could induce widespread mTOR phosphorylation in both male and female mice. Pretreatment with the mTOR inhibitor rapamycin not only prevented anesthesia-induced mTOR phosphorylation, but also the increase in mitochondrial respiration and male-dependent enhancement of excitatory synaptic transmission. However, the changes in inhibitory synaptic transmission that appear after anesthesia in female mice were not affected by rapamycin pretreatment. Our results suggest that mTOR inhibitors may act as potential therapeutic agents for anesthesia-induced changes in the developing brain.
Introduction
Preclinical animal studies continuously report possible neurotoxic effects from anesthesia in young rodents, sheep, and non-human primates (Olutoye et al., 2016; Jevtovic-Todorovic, 2018). The United States Food and Drug Administration (U.S. FDA) has therefore published warnings regarding the repeated or prolonged use of anesthesia in children under age 3 years. Fortunately, recent clinical studies strongly suggest that a single, short exposure to anesthetic does not affect neurodevelopment (O’Leary and Warner, 2017; Warner et al., 2018; McCann et al., 2019). However, there are still concerns regarding multiple anesthetic exposures (Warner et al., 2018; Zaccariello et al., 2019).
Previous studies also show that anesthesia-induced neurotoxicity depends on their neurodevelopmental stage. While anesthesia induces neuronal cell death in neonatal mice, the same anesthetics induces excitatory/inhibitory imbalance in late postnatal mice (Briner et al., 2010; Chung et al., 2017a; Ju et al., 2019). Importantly, excitatory/inhibitory imbalance has been linked to diverse neurodevelopmental disorders (Meredith, 2015; Lee et al., 2017). Because most procedures requiring anesthesia in humans are performed during the postnatal period, these anesthesia-induced changes in late postnatal mice may be of great importance, as the neurodevelopment of mice during this stage may be equivalent to the neurodevelopment of human infants (Workman et al., 2013). However, the mechanisms underlying anesthesia-induced changes in late postnatal mice are still not completely understood.
The mammalian target of rapamycin (mTOR), a serine/threonine kinase, controls intra-cellular functions including protein synthesis, energy metabolism, cell survival, autophagy and mitochondria biogenesis in peripheral tissues. In the nervous system, mTOR pathway regulates axonal sprouting, axonal regeneration and myelination, ion channel and receptor expression, and dendritic spine growth (Bockaert and Marin, 2015; Huber et al., 2015). Previous studies also show that activation of mTOR enhances synaptic activity by promoting AMPA receptor synthesis and expression at the cell surface (Wang et al., 2006; Ran et al., 2013). In addition, mTOR regulates dendritic spine development and formation (Tavazoie et al., 2005; Lee et al., 2011), and excitatory synaptic transmission (Tang et al., 2002; Cammalleri et al., 2003). As exposure to anesthetics increase synaptic proteins, dendritic spinogenesis, and induce excitatory/inhibitory imbalance (Briner et al., 2010; Chung et al., 2017a; Ju et al., 2019), it is highly possible that mTOR signaling is involved with these anesthesia-induced changes. Indeed, previous studies show that anesthetics increase mTOR signaling in various ages (Li et al., 2010, 2017; Zhang et al., 2014; Kang et al., 2017). For example, injection of ketamine in adult mice was found to induce mTOR activation, accompanied by increased spinogenesis and excitatory synaptic transmission (Li et al., 2010). Isoflurane induction of anesthesia in postnatal day (PND) 15 mice was found to induce long-lasting mTOR pathway activation in the dentate gyrus, leading to changes in dendritic arbors, dendritic spines numbers, and impaired learning and memory (Kang et al., 2017). These changes were prevented by the mTOR pathway inhibitor rapamycin. However, the exact role of mTOR after general anesthesia in late postnatal mice has not been sufficiently evaluated.
To evaluate the role of mTOR signaling following anesthesia in late postnatal mice, PND 16/17 mice were exposed to 2.5% sevoflurane (the most widely used inhalation agent in pediatric patients) for 2 h. Administration of sevoflurane to PND 16/17 mice has been shown to increase dendritic spine formation, to alter mitochondrial function, and to induce sex-dependent changes in excitatory/inhibitory synaptic transmission (Chung et al., 2017a; Ju et al., 2019). Based on previous findings, this study hypothesized that sevoflurane-induced changes in late postnatal mice could be prevented by inhibiting the mTOR pathway with rapamycin.
Materials and Methods
Animals
All experiments were approved by the relevant Committees of Chungnam National University, Daejeon, South Korea (CNU-01135). C57BL/6J mice were maintained in a specific pathogen-free (SPF) room maintained at 22°C, with a 12 h light/dark cycle, and fed ad libitum. Animals received anesthesia during the light cycle. This research adheres to the ARRIVE (Animal Research: Reporting in vivo Experiments) guidelines.
Anesthesia
PND 16/17 mice were randomly divided into three groups: control, sevoflurane, and sevoflurane plus rapamycin groups. Mice in the sevoflurane and sevoflurane plus rapamycin groups were placed in a 1-l plastic chamber and exposed to a constant flow of fresh gas [fraction of inspired oxygen (FiO2) 0.4, 4 L/min] containing 2.5% sevoflurane for 2 h. Full recovery was confirmed 30 min after discontinuing sevoflurane. Control mice were treated identically but without sevoflurane. The anesthesia chamber was placed in a 36°C water bath to maintain a constant temperature. Carbon dioxide and sevoflurane were monitored using an S/5 compact anesthetic monitor and a mCAiO gas analyzer module (Datex-Ohmeda, Helsinki, Finland).
Rapamycin Treatment
Rapamycin (LC Laboratories, Woburn, MA, USA) was reconstituted in ethanol at a concentration 10 μg/μl and then diluted in 5% Tween-80 (Sigma–Aldrich, St. Louis, MO, USA) and 5% PEG-400 (Sigma–Aldrich, St. Louis, MO, USA), as described (Chen et al., 2009). Mice in the sevoflurane plus rapamycin group were each administered three intraperitoneal injections of rapamycin (5 mg/kg) at 24 h intervals prior to sevoflurane exposure, whereas mice in the control and sevoflurane groups were injected with an identical volume of vehicle.
Western blotting
Whole-brain samples were obtained from the mice 24 h after sevoflurane exposure. Mice were exposed to carbon dioxide before brain extraction, and each whole brain was homogenized with a tissue grinder in RIPA lysis buffer [ELPIS-BIOTECH, Daejeon, South Korea, 100 mM Tris–hydrochloride (pH 8.5), 200 mM NaCl, 5 mM EDTA, and 0.2% sodium dodecyl sulfate], containing phosphatase and protease inhibitor cocktails (Sigma–Aldrich). After centrifuging the homogenized samples at 12,000× g for 15 min at 4°C, the supernatants were decanted and their protein concentrations were measured using the Bradford assay (Bio-Rad, Hercules, CA, USA). Samples (20 μg) were electrophoresed on SDS PAGE gels, and transferred to nitrocellulose membranes (pore size, 0.2 μm; Amersham Protran®, GE Healthcare, Buckinghamshire, UK) at 200 mA for 2 h. The membranes were blocked for 1 h with Tris-buffered saline-Tween 20 [10 mM Tris–hydrochloride (pH 7.6), 150 mM NaCl, and 0.1% Tween 20], containing 3% bovine serum albumin (BSA), followed by incubation with primary antibodies and the appropriate secondary antibodies coupled to horseradish peroxidase. Specific antibody-labeled proteins were detected using the enhanced chemiluminescence system (WEST-ZOL plus; iNtRON BioTechnology, Seongnam, South Korea). Primary antibodies included antibodies to phospho-mTOR(S2448), mTOR (Cell Signaling Technology, Danvers, MA, USA), postsynaptic density 90 (PSD95; Neuromab, Davis, CA, USA), GAD65 (Abcam, Cambridge, UK), NDUFB8 (a mitochondrial complex I subunit; Santa Cruz Biotechnology, Santa Cruz, TX, USA), COX4 (a mitochondrial complex IV subunit; Novus Biologicals, Centennial, CO, USA) and actin (Santa Cruz Biotechnology, Santa Cruz, TX, USA). Antibodies against GluA1 (1193) and GluA2 (1195) have been described previously (Kim et al., 2009).
Oxygen Consumption Rate
Mitochondria were isolated from brain tissues 24 h after sevoflurane exposure, as previously described (Chung et al., 2017a). Each brain was homogenized in a mitochondrial isolation buffer [70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM EGTA, and 0.5% (w/v) fatty acid–free BSA (pH 7.2)] with a Teflon-glass homogenizer (Thomas Fisher Scientific, Swedesboro, NJ, USA). After centrifugation at 600× g for 10 min at 4°C and at 17,000× g for 10 min at 4°C, the mitochondrial fraction was resuspended in a mitochondrial isolation buffer. Protein concentration was measured by the Bradford assay (Bio-Rad), and 20 μg aliquots of protein were diluted with 50 μl mitochondrial assay solution [70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% (w/v) fatty acid–free BSA, 10 mM succinate, and 2 μM rotenone (pH 7.2)] and seeded in an XF-24 plate (Seahorse Bioscience, North Billerica, MA, USA). The plates were centrifuged at 2,000× g for 20 min at 4°C using a swinging bucket microplate adaptor (Eppendorf, Hamburg, Germany); 450 μl mitochondrial assay buffer was added to each plate, and the plates were maintained at 37°C for 8–10 min. Each plate was transferred to a Seahorse XF-24 extracellular flux analyzer (Seahorse Bioscience) and the oxygen consumption rate (OCR) was measured at five stages: stage I (basal level); stage II, following the addition of adenosine diphosphate (ADP); stage III, following the addition of oligomycin, a mitochondrial oxidative phosphorylation (OXPHOS) complex 5 inhibitor; stage IV, following the addition of carbonyl cyanide m-chlorophenyl hydrazine (CCCP), a mitochondrial OXPHOS complex 4 inhibitor; and stage V, following the addition of antimycin A, a mitochondrial OXPHOS complex 3 inhibitor. OCR was automatically calculated and recorded using Seahorse XF-24 software (Seahorse Bioscience).
Electrophysiology
Whole-cell voltage-clamp recordings of pyramidal neurons in the CA1 region of the hippocampus were obtained as described (Chung et al., 2015a). Twenty-four hours after exposure to sevoflurane or fresh gas, sagittal slices of the hippocampus (300 μm) were prepared in ice-cold dissection buffer (212 mM sucrose, 25 mM NaHCO3, 5 mM KCl, 1.25 mM NaH2PO4, 10 mM d-glucose, 2 mM sodium pyruvate, 1.2 mM sodium ascorbate, 3.5 mM MgCl2, and 0.5 mM CaCl2) aerated with 95% O2/5% CO2, using a VT1200S vibratome (Leica, Arrau, Switzerland). Slices were transferred immediately to a 32°C chamber containing artificial cerebrospinal fluid (aCSF: 125 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 10 mM d-glucose, 1.3 mM MgCl2, and 2.5 mM CaCl2, continuously aerated with 95% O2/5% CO2) and incubated for 30 min. Glass capillaries were filled with two kinds of internal solutions. For miniature excitatory postsynaptic current (mEPSC) recordings, the glass capillaries were filled with an internal solution containing 117 mM CsMeSO4, 10 mM tetraethylammonium chloride, 8 mM NaCl, 10 mM HEPES, 5 mM QX-314-Cl, 4 mM Mg-adenosine triphosphate (ATP), 0.3 mM Na-guanosine triphosphate, and 10 mM EGTA; for miniature inhibitory postsynaptic current (mIPSC) recordings, the glass capillaries were filled with an internal solution containing 115 mM CsCl, 10 mM tetraethylammonium chloride, 8 mM NaCl, 10 mM HEPES, 5 mM QX-314-Cl, 4 mM Mg-ATP, 0.3 mM Na-guanosine triphosphate, and 10 mM EGTA. Whole-cell recordings were performed under visual control (BX50WI; Olympus, Tokyo, Japan) with a multi clamp 700A amplifier (Molecular Devices, San Jose, CA, USA). Data were acquired with Clampex 9.2 (Molecular Devices, San Jose, CA, USA) and analyzed using Clampfit 9 software (Molecular Devices, San Jose, CA, USA).
Statistical Analysis
The sample size was determined based on previous experience or as previously described (Chung et al., 2015b, 2017b). All statistical analyses were performed using R statistical software (3.1.2: R Core Team, Austria). All continuous variables were tested to determine whether they met conditions of normality and homogeneity of variance. One-way ANOVA with post hoc Tukey HSD test was performed when both conditions were met, Welch’s ANOVA with post hoc Tukey HSD test was performed when homogeneity of variance was unmet, and the Kruskal–Wallis test with post hoc Dunn’s test was performed if normality was unmet. P < 0.05 was considered statistically significant. Statistical results are presented as Supplementary Statistics.
Results
Sevoflurane Exposure in PND 16/17 Mice Induces Widespread Activation of the mTOR Signaling Pathway
To assess that sevoflurane induces widespread activation of the mTOR signaling pathway, the level of mTOR phosphorylation was measured by western blotting in whole brain samples obtained 24 h after sevoflurane exposure. We also evaluated whether three daily injections of rapamycin prior to sevoflurane exposure could prevent mTOR phosphorylation (Figure 1A). Because we had found that sevoflurane changes were sex-dependent, mTOR phosphorylation was separately measured in male and female mice. Sevoflurane exposure enhanced phosphorylation of mTOR in both male and female mice, and such phosphorylation was blocked in both sexes by rapamycin injection (Figures 1B–E).
Figure 1
Rapamycin Treatment Prevents a Sevoflurane-Induced Increase of Mitochondrial Function in PND 16/17 Mice
We previously reported that mitochondrial respiration continuously increases for up to 9 h after sevoflurane exposure in PND 16/17 mice (Chung et al., 2017a). Mitochondrial respiration, which is conducted by assembled mitochondrial and nuclear-originated proteins, produces ATP by consuming oxygen. To determine the association between mTOR signaling and sevoflurane-induced changes in mitochondrial respiration, the amounts of the OXPHOS complex subunit proteins NADH: Ubiquinone Oxidoreductase Subunit B8 (NDUFB8; subunit of OXPHOS complex I) and cytochrome c oxidase subunit 4 (COX4; subunit of OXPHOS complex IV) were measured 24 h after sevoflurane exposure. Sevoflurane increased the level of NDUFB8, but not of COX4, only in female mice. The increase was inhibited by preinjection with rapamycin (Figures 2A–D). To assess mitochondrial respiration 24 h after sevoflurane exposure, we also measured the OCR in mitochondria isolated from whole brains (Figures 2E–H). Sevoflurane exposure increased basal OCR (stage I) only in female mice, but increased ADP-induced OCR (stage II), oligomycin induced ATP production (stage III), and maximal OCR (stage IV) in both male and female mice. These changes were prevented by rapamycin pretreatment in both male and female mice (Figures 2F,H). Taken together, these results showed that sevoflurane-induced changes in mitochondrial function in an mTOR dependent manner.
Figure 2
Rapamycin Treatment Prevents a Sevoflurane-Induced Increase of AMPA Receptor Subunit GluA2 in PND 16/17 Male Mice
We previously reported that a single exposure of PND 16/17 mice to sevoflurane affects the level of expression of synaptic molecules 6 h later (Chung et al., 2017a; Ju et al., 2019). To confirm longer-lasting changes in expression and to determine the role of mTOR signaling, western blotting was performed 24 h after sevoflurane exposure. The expression of GluA2 was significantly increased only in male mice, while there were no significant changes in female mice (Figure 3). The increase in GluA2 expression was inhibited by rapamycin pretreatment, suggesting that the mTOR pathway is also associated with changes in protein expression after exposure to sevoflurane in male mice.
Figure 3
Rapamycin Treatment Prevents Sevoflurane-Induced Changes of Excitatory Synaptic Transmission in Male Mice But Does Not Prevent Changes of Inhibitory Synaptic Transmission in Female Mice
Exposure of PND 16/17 mice to sevoflurane was shown to induce acute, sex-dependent changes in various brain regions (Chung et al., 2017a; Ju et al., 2019). To extend these findings, we assessed changes of excitatory/inhibitory synaptic transmission in CA1 pyramidal neurons in the hippocampus 24 h after sevoflurane exposure. Sevoflurane increased mEPSC frequency only in male mice (Figure 4), an increase blocked by preinjection of rapamycin (Figures 4A,B). In contrast, sevoflurane affected mIPSC frequency only in female mice (Figure 5), but these changes were unaffected by preinjection of rapamycin (Figures 5C,D). These results suggest that only the sex-dependent changes in excitatory synaptic transmission are mTOR dependent.
Figure 4
Figure 5
Discussion
Few studies to date have analyzed the mechanisms underlying changes in synaptic transmission after exposure to anesthesia in late postnatal mice. To gain further insight and to identify a possible molecular target for preventing such anesthesia-induced changes, we focused on the mTOR pathway due to the fact that mTOR signaling regulates mitochondrial function (Ramanathan and Schreiber, 2009; Morita et al., 2015, 2017), dendritic spine formation, AMPA receptor synthesis, and excitatory synaptic transmission (Bockaert and Marin, 2015). Our results indicate that the mTOR pathway is associated with the changes that occur after anesthetic exposure in late postnatal male mice.
Neuronal mitochondrial function has been shown to be involved with dendritic spine formation and synaptic transmission (Li et al., 2004; Guo et al., 2017; Rossi and Pekkurnaz, 2019). Since anesthetic exposure increases spinogenesis and induces change in synaptic transmission, we previously suggested the compensatory increase of mitochondria function as a possible mechanism (Chung et al., 2017a). However, we were unable to provide a mechanism by which sevoflurane increased mitochondrial function. Previous studies have suggested that the mTOR complex stimulates the synthesis of mitochondrial components by regulating translation (Morita et al., 2013). In our present study, we also suggest that mTOR regulates sevoflurane-induced changes in mitochondrial function by showing that rapamycin pretreatment efficiently blocks the sevoflurane-induced increases in mitochondrial OCR in both male and female mice. While our results suggest that mTOR may regulate the sevoflurane-induced neurological changes through mitochondrial activation, many studies also show that mTOR signaling itself is an important regulator of dendritic spine formation, AMPA receptor synthesis, and excitatory synaptic transmission (Bockaert and Marin, 2015). Thus, inhibition of the mTOR pathway can prevent the anesthesia-induced changes in a mitochondrial-independent fashion as well. However, considering previous evidence regarding the significance of mitochondrial function with neurological changes, it is highly possible that mTOR regulates the sevoflurane-induced changes through both mitochondrial-dependent and independent pathways.
Sex is recognized as a valuable biological variable in neuroscience (Shansky and Woolley, 2016; Bale and Epperson, 2017; Torres-Rojas and Jones, 2018), and has been shown to affect anesthesia-induced neurotoxicity during neurodevelopment in young animals (Boscolo et al., 2013; Ju et al., 2019). Unfortunately, the majority of clinical studies have been performed with male patients (Lin et al., 2017), and the clinical significance of sex is still in need of further evaluation. Several sex-dependent changes were also discovered in our present study. First, while sevoflurane activates mTOR in both sexes, mTOR-dependent increases in AMPA receptor subunit expression and excitatory synaptic transmission only occurred in male mice. This may be due to sex-dependent differences in the downstream signaling of mTOR. A previous study has shown different downstream activities between male and female mice in non-neural tissues. For instance, when compared to female mice, male mice showed decreased basal mTORC1 activity in the liver and heart tissue, while the basal mTORC2 activity was increased in muscle tissue (Baar et al., 2016). Sevoflurane-induced mTOR activation may result in male-dependent changes due to differences in mTOR downstream signaling in male and female mice. Second, sevoflurane exposure induced different mitochondrial changes between sexes. When measured 24 h after sevoflurane exposure, male mice displayed increases of ADP induced OCR, maximal OCR and ATP production without changes in basal OCR and OXPHOS subunit protein levels. However, all stages of the mitochondrial OCR and OXPHOS subunit protein levels were still increased in female mice. Such discrepancies between male and female mice may be due to the differences in mitochondrial respiratory function, morphology, and reactive oxygen species (ROS) homeostasis (Khalifa et al., 2017). Previous studies also show sex-dependent differences in mitochondrial biogenesis after oxygen-glucose deprivation and reoxygenation (Sharma et al., 2014). Another interesting fact is that sevoflurane-induced activation of the mTOR pathway can sex-dependently affect the expression of a specific set of proteins, as female mice show more significant changes for a mitochondrial protein, but male mice display more difference in an excitatory synaptic protein. While this may be due to distinct downstream mTOR signaling between male and female mice as mentioned above, distinct gene expression (sexually dimorphic genes) and epigenetic sex differences may also be involved (Yang et al., 2006; McCarthy and Nugent, 2015).
An important factor in our study was the duration of rapamycin treatment. Initially, the experiments involved a single injection of rapamycin (Supplementary Figure S1). Although this single injection restored the phosphorylation level of mTOR, it did not prevent the sevoflurane-induced increase in mEPSC frequency in male mice. We next used a daily injection of rapamycin (5 mg/kg/day) for three consecutive days based on previous studies (Zeng et al., 2009; Huang et al., 2010; Hartman et al., 2012). Unlike a single injection, multiple rapamycin injections were capable of preventing the sevoflurane-induced increase in excitatory synaptic transmission. mTOR acts by forming two distinct protein complexes, mTOR Complex 1 (mTORC1) and mTOR Complex 2 (mTORC2). Despite rapamycin being an mTOR inhibitor, prolonged rapamycin treatment is required to block mTORC2. One possible explanation is that blockade of mTORC2 by multiple rapamycin injections is required to block changes in excitatory synaptic transmission.
Another interesting finding of our study is that the female-dependent changes in inhibitory synaptic transmission after sevoflurane exposure seems to be irrelevant of mTOR signaling, as rapamycin pretreatment did not affect inhibitory synaptic transmission in both male and female mice. Also, the changes of inhibitory synaptic transmission observed 24 h after sevoflurane exposure was different than the changes observed shortly after anesthesia induction (Chung et al., 2017a; Ju et al., 2019). Whereas mIPSC frequency increased in female mice 6 h after sevoflurane exposure (Ju et al., 2019), mIPSC frequency decreased 24 h after exposure. Genetic mouse models of neurodevelopmental disorders have also shown reversed changes in synaptic transmission during development (Chung et al., 2019). Although these reversed changes may be due to compensation mechanisms, more studies focusing on the mechanism behind time-dependent changes in inhibitory synaptic transmission in female mice are required.
This study has several limitations. Although the oxygen concentration during anesthesia was relatively low (FiO2 0.4), thereby avoiding oxygen toxicity, we are unable to rule out the effects of slight changes in arterial carbon dioxide (PaCO2) and blood pH after exposure to sevoflurane for 2 h (Chung et al., 2017a). Another limitation was the inconsistency of brain regions among experiments. Western blot and mitochondrial experiments were performed using whole-brain samples, enabling us to confirm widespread changes in mTOR signaling and mitochondrial function. However, electrophysiology experiments were performed using only hippocampal neurons. We have previously reported that sevoflurane exposure induces similar, but slightly different, changes in different brain regions (Chung et al., 2017a; Ju et al., 2019). Since the importance of sex regarding sevoflurane-induced changes were more thoroughly addressed in the hippocampus, we evaluated the possible sex-dependent effects of rapamycin in the hippocampus (CA1 region).
In conclusion, exposure of PND 16/17 mice to sevoflurane induces mTOR phosphorylation, leading to enhanced mitochondrial function and male-dependent excitatory synaptic transmission. Although further studies regarding the mechanism behind inhibitory synaptic changes in female mice are necessary, our results suggest that mTOR inhibitors may be potential therapeutic agents for anesthesia-induced changes during neurodevelopment.
Statements
Data availability statement
All datasets generated for this study are included in the article/Supplementary Material.
Ethics statement
The animal study was reviewed and approved by Committees of Chungnam National University, Daejeon, South Korea (CNU-01135). Written informed consent was obtained from the owners for the participation of their animals in this study.
Author contributions
XJ and MR: helped design, development, execution of experiments and preparation of manuscript. SP and BH: helped perform the statistics. JC, YL and SY: helped execution of experiments. WL, YS, S-HY, GK, YHK and YK: helped design and development of experiments, oversight. WC and JH: helped design, development and execution of experiments, oversight, preparation of manuscript.
Funding
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (NRF-2018R1C1B6003139, NRF-2017R1A5A2015385, NRF-2019M3E5D1A02068575) and by the research fund of Chungnam national university hospital (2019-1569-01).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fncel.2020.00004/full#supplementary-material.
References
1
BaarE. L.CarbajalK. A.OngI. M.LammingD. W. (2016). Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice. Aging Cell15, 155–166. 10.1111/acel.12425
2
BaleT. L.EppersonC. N. (2017). Sex as a biological variable: who, what, when, why and how. Neuropsychopharmacology42, 386–396. 10.1038/npp.2016.215
3
BockaertJ.MarinP. (2015). mTOR in brain physiology and pathologies. Physiol. Rev.95, 1157–1187. 10.1152/physrev.00038.2014
4
BoscoloA.OriC.BennettJ.WiltgenB.Jevtovic-TodorovicV. (2013). Mitochondrial protectant pramipexole prevents sex-specific long-term cognitive impairment from early anaesthesia exposure in rats. Br. J. Anaesth.110, i47–52. 10.1093/bja/aet073
5
BrinerA.De RooM.DayerA.MullerD.HabreW.VutskitsL. (2010). Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology112, 546–556. 10.1097/aln.0b013e3181cd7942
6
CammalleriM.LutjensR.BertonF.KingA. R.SimpsonC.FrancesconiW.et al. (2003). Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl. Acad. Sci. U S A100, 14368–14373. 10.1073/pnas.2336098100
7
ChenC.LiuY.LiuY.ZhengP. (2009). mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal.2:ra75. 10.1126/scisignal.2000559
8
ChungC.HaS.KangH.LeeJ.UmS. M.YanH.et al. (2019). Early correction of N-Methyl-D-Aspartate receptor function improves autistic-like social behaviors in adult Shank2−/− mice. Biol. Psychiatry85, 534–543. 10.1016/j.biopsych.2018.09.025
9
ChungW.ChoiS. Y.LeeE.ParkH.KangJ.ParkH.et al. (2015a). Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression. Nat. Neurosci.18, 435–443. 10.1038/nn.3927
10
ChungW.ParkS.HongJ.ParkS.LeeS.HeoJ.et al. (2015b). Sevoflurane exposure during the neonatal period induces long-term memory impairment but not autism-like behaviors. Paediatr. Anaesth.25, 1033–1045. 10.1111/pan.12694
11
ChungW.RyuM. J.HeoJ. Y.LeeS.YoonS.ParkH.et al. (2017a). Sevoflurane exposure during the critical period affects synaptic transmission and mitochondrial respiration but not long-term behavior in mice. Anesthesiology126, 288–299. 10.1097/aln.0000000000001470
12
ChungW.YoonS.ShinY. S. (2017b). Multiple exposures of sevoflurane during pregnancy induces memory impairment in young female offspring mice. Korean J. Anesthesiol.70, 642–647. 10.4097/kjae.2017.70.6.642
13
GuoL.TianJ.DuH. (2017). Mitochondrial dysfunction and synaptic transmission failure in Alzheimer’s disease. J. Alzheimers Dis.57, 1071–1086. 10.3233/jad-160702
14
HartmanA. L.SantosP.DolceA.HardwickJ. M. (2012). The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice. PLoS One7:e45156. 10.1371/journal.pone.0045156
15
HuangX.ZhangH.YangJ.WuJ.McmahonJ.LinY.et al. (2010). Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol. Dis.40, 193–199. 10.1016/j.nbd.2010.05.024
16
HuberK. M.KlannE.Costa-MattioliM.ZukinR. S. (2015). Dysregulation of mammalian target of rapamycin signaling in mouse models of autism. J. Neurosci.35, 13836–13842. 10.1523/jneurosci.2656-15.2015
17
Jevtovic-TodorovicV. (2018). Exposure of developing brain to general anesthesia: what is the animal evidence?Anesthesiology128, 832–839. 10.1097/aln.0000000000002047
18
JuX.JangY.HeoJ. Y.ParkJ.YunS.ParkS.et al. (2019). Anesthesia affects excitatory/inhibitory synapses during the critical synaptogenic period in the hippocampus of young mice: importance of sex as a biological variable. Neurotoxicology70, 146–153. 10.1016/j.neuro.2018.11.014
19
KangE.JiangD.RyuY. K.LimS.KwakM.GrayC. D.et al. (2017). Early postnatal exposure to isoflurane causes cognitive deficits and disrupts development of newborn hippocampal neurons via activation of the mTOR pathway. PLoS Biol.15:e2001246. 10.1371/journal.pbio.2001246
20
KhalifaA. R.Abdel-RahmanE. A.MahmoudA. M.AliM. H.NoureldinM.SaberS. H.et al. (2017). Sex-specific differences in mitochondria biogenesis, morphology, respiratory function and ROS homeostasis in young mouse heart and brain. Physiol. Rep.5:e13125. 10.14814/phy2.13125
21
KimM. H.ChoiJ.YangJ.ChungW.KimJ. H.PaikS. K.et al. (2009). Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation and impaired learning and memory in mice lacking IRSp53. J. Neurosci.29, 1586–1595. 10.1523/jneurosci.4306-08.2009
22
LeeC. C.HuangC. C.HsuK. S. (2011). Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology61, 867–879. 10.1016/j.neuropharm.2011.06.003
23
LeeE.LeeJ.KimE. (2017). Excitation/inhibition imbalance in animal models of autism spectrum disorders. Biol. Psychiatry81, 838–847. 10.1016/j.biopsych.2016.05.011
24
LiN.LeeB.LiuR. J.BanasrM.DwyerJ. M.IwataM.et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science329, 959–964. 10.1126/science.1190287
25
LiX.WuZ.ZhangY.XuY.HanG.ZhaoP. (2017). Activation of autophagy contributes to sevoflurane-induced neurotoxicity in fetal rats. Front. Mol. Neurosci.10:432. 10.3389/fnmol.2017.00432
26
LiZ.OkamotoK.HayashiY.ShengM. (2004). The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell119, 873–887. 10.1016/j.cell.2004.11.003
27
LinE. P.LeeJ. R.LeeC. S.DengM.LoepkeA. W. (2017). Do anesthetics harm the developing human brain? An integrative analysis of animal and human studies. Neurotoxicol. Teratol.60, 117–128. 10.1016/j.ntt.2016.10.008
28
McCannM. E.De GraaffJ. C.DorrisL.DismaN.WithingtonD.BellG.et al. (2019). Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial. Lancet393, 664–677. 10.1016/S0140-6736(18)32485-1
29
McCarthyM. M.NugentB. M. (2015). At the frontier of epigenetics of brain sex differences. Front. Behav. Neurosci.9:221. 10.3389/fnbeh.2015.00221
30
MeredithR. M. (2015). Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders. Neurosci. Biobehav. Rev.50, 180–188. 10.1016/j.neubiorev.2014.12.001
31
MoritaM.GravelS. P.ChenardV.SikstromK.ZhengL.AlainT.et al. (2013). mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab.18, 698–711. 10.1016/j.cmet.2013.10.001
32
MoritaM.GravelS. P.HuleaL.LarssonO.PollakM.St-PierreJ.et al. (2015). mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle14, 473–480. 10.4161/15384101.2014.991572
33
MoritaM.PrudentJ.BasuK.GoyonV.KatsumuraS.HuleaL.et al. (2017). mTOR controls mitochondrial dynamics and cell survival via MTFP1. Mol. Cell67, 922.e925–935.e925. 10.1016/j.molcel.2017.08.013
34
O’LearyJ. D.WarnerD. O. (2017). What do recent human studies tell us about the association between anaesthesia in young children and neurodevelopmental outcomes?Br. J. Anaesth.119, 458–464. 10.1093/bja/aex141
35
OlutoyeO. A.SheikhF.ZamoraI. J.YuL.AkinkuotuA. C.AdesinaA. M.et al. (2016). Repeated isoflurane exposure and neuroapoptosis in the midgestation fetal sheep brain. Am. J. Obstet. Gynecol.214, 542.e541–542.e548. 10.1016/j.ajog.2015.10.927
36
RamanathanA.SchreiberS. L. (2009). Direct control of mitochondrial function by mTOR. Proc. Natl. Acad. Sci. U S A106, 22229–22232. 10.1073/pnas.0912074106
37
RanI.GkogkasC. G.VasutaC.TartasM.KhoutorskyA.LaplanteI.et al. (2013). Selective regulation of GluA subunit synthesis and AMPA receptor-mediated synaptic function and plasticity by the translation repressor 4E-BP2 in hippocampal pyramidal cells. J. Neurosci.33, 1872–1886. 10.1523/jneurosci.3264-12.2013
38
RossiM. J.PekkurnazG. (2019). Powerhouse of the mind: mitochondrial plasticity at the synapse. Curr. Opin. Neurobiol.57, 149–155. 10.1016/j.conb.2019.02.001
39
ShanskyR. M.WoolleyC. S. (2016). Considering sex as a biological variable will be valuable for neuroscience research. J. Neurosci.36, 11817–11822. 10.1523/jneurosci.1390-16.2016
40
SharmaJ.JohnstonM. V.HossainM. A. (2014). Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci.15:9. 10.1186/1471-2202-15-9
41
TangS. J.ReisG.KangH.GingrasA. C.SonenbergN.SchumanE. M. (2002). A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl. Acad. Sci. U S A99, 467–472. 10.1073/pnas.012605299
42
TavazoieS. F.AlvarezV. A.RidenourD. A.KwiatkowskiD. J.SabatiniB. L. (2005). Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci.8, 1727–1734. 10.1038/nn1566
43
Torres-RojasC.JonesB. C. (2018). Sex differences in neurotoxicogenetics. Front. Genet.9:196. 10.3389/fgene.2018.00196
44
WangY.BarbaroM. F.BarabanS. C. (2006). A role for the mTOR pathway in surface expression of AMPA receptors. Neurosci. Lett.401, 35–39. 10.1016/j.neulet.2006.03.011
45
WarnerD. O.ZaccarielloM. J.KatusicS. K.SchroederD. R.HansonA. C.SchulteP. J.et al. (2018). Neuropsychological and behavioral outcomes after exposure of young children to procedures requiring general anesthesia: the mayo anesthesia safety in kids (MASK) study. Anesthesiology129, 89–105. 10.1097/ALN.0000000000002232
46
WorkmanA. D.CharvetC. J.ClancyB.DarlingtonR. B.FinlayB. L. (2013). Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci.33, 7368–7383. 10.1523/JNEUROSCI.5746-12.2013
47
YangX.SchadtE. E.WangS.WangH.ArnoldA. P.Ingram-DrakeL.et al. (2006). Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res.16, 995–1004. 10.1101/gr.5217506
48
ZaccarielloM. J.FrankR. D.LeeM.KirschA. C.SchroederD. R.HansonA. C.et al. (2019). Patterns of neuropsychological changes after general anaesthesia in young children: secondary analysis of the mayo anesthesia safety in kids study. Br. J. Anaesth.122, 671–681. 10.1016/j.bja.2019.01.022
49
ZengL. H.RensingN. R.WongM. (2009). The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci.29, 6964–6972. 10.1523/jneurosci.0066-09.2009
50
ZhangJ.WangC.YuS.LuoZ.ChenY.LiuQ.et al. (2014). Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling. Sci. Rep.4:7317. 10.1038/srep07317
Summary
Keywords
general anesthesia, mTOR, neurodevelopment, neurotoxicity, synaptic transmission
Citation
Ju X, Ryu MJ, Cui J, Lee Y, Park S, Hong B, Yoo S, Lee WH, Shin YS, Yoon S-H, Kweon GR, Kim YH, Ko Y, Heo JY and Chung W (2020) The mTOR Inhibitor Rapamycin Prevents General Anesthesia-Induced Changes in Synaptic Transmission and Mitochondrial Respiration in Late Postnatal Mice. Front. Cell. Neurosci. 14:4. doi: 10.3389/fncel.2020.00004
Received
06 August 2019
Accepted
09 January 2020
Published
28 January 2020
Volume
14 - 2020
Edited by
Julie S. Haas, Lehigh University, United States
Reviewed by
Se-Young Choi, Seoul National University, South Korea; Seok-Kyu Kwon, Korea Institute of Science and Technology (KIST), South Korea
Updates
Copyright
© 2020 Ju, Ryu, Cui, Lee, Park, Hong, Yoo, Lee, Shin, Yoon, Kweon, Kim, Ko, Heo and Chung.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jun Young Heo junyoung3@gmail.comWoosuk Chung woosuk119@gmail.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.